HRX Innovation Challenge: Deadline is June 3, 2024

HRX Innovation Challenge: Deadline is June 3, 2024

Event category: Main Tent


September 06, 2024


02:45 PM (EDT) - 03:45 PM (EDT)

Main Stage

Nishaki Mehta

The Top 5 scoring AbstracX Researchers will share their research.

Nishaki Mehta

Associate Professor of Medicine

William Beaumont Oakland University School of Medicine

September 05, 2024


03:30 PM (EDT) - 04:30 PM (EDT)

Payal Cramer | Krystina Monticello

Payal Cramer


Baker & Hostetler LLP

September 07, 2024


09:15 AM (EDT) - 10:30 AM (EDT)

Main Stage

Robert Kowal (Judge)

The HRX 2024 Pitch Competition provides cardiovascular startups with a platform to present their innovative products, services, and solutions to a distinguished panel of judges and potential investors and win cash prices
The top five teams selected will compete on the HRX Main Stage. Each team will have 10 minutes to creatively pitch their innovative idea, followed by five minutes to field questions from judges and attendees.

Robert Kowal

Vice President and General Manager, Cardiac Pacing Therapies | Cardiac Electrophysiologist



01:30 PM (EDT) - 02:15 PM (EDT)

Main Stage

Atul Butte | Hamid Ghanbari

Atul Butte, MD, PhD

Priscilla Chan and Mark Zuckerberg Distinguished Professor; Director, Bakar Computational Health Sciences Institute


Hamid Ghanbari

Vice Chair of Innovation, Assistant Professor & Cardiac Electrophysiologist

University of Michigan Cardiovascular Center

September 06, 2024


04:30 PM (EDT) - 05:30 PM (EDT)

Main Stage

Shivani Fernando | Jennifer Jones-McMeans

Cardiovascular disease is the number one killer of women. Women continue to be undertreated for cardiovascular problems compared to men, are less likely to receive bystander CPR, and are more likely to die after having a heart attack. Meanwhile, women also experience unique life events that can impact their risk, including pregnancy and menopause. The addressable market and the unmet need for cardiovascular health promotion in women is great, and yet the majority of women’s digital health funding is concentrated in maternal and reproductive health.

What are the cultural and structural barriers for developing cardiovascular digital health solutions for women? How might femtech companies increase public awareness of cardiovascular disease risk? What is the role of female representation among researchers, inventors, investors, and founders? Join incredible women leaders in tech to candidly discuss this pivotal time in women’s health innovation.

Shivani Fernando

Founder & CEO | WBJ 40 under 40 (2022)| TedX Speaker | VR, WEB Designer Developer


Jennifer Jones-McMeans

Divisional Vice President of Global Clinical Affair



01:30 PM (EDT) - 02:30 PM (EDT)

Main Stage

Janet Han | Katie Adams | Caitlin Cox

Katie Adams

Senior Reporter

MedCity News

Caitlin Cox

News Editor | Associate Director of Editorial Content

TCTMD | Cardiovascular Research Foundation

Janet K. Han

Associate Professor of Medicine | Cardiac Electrophysiology

UCLA | VA Greater Los Angeles Healthcare System / UCLA | Digital Health & Virtual Care


11:30 AM (EDT) - 12:15 AM (EDT)

Main Stage

Jennifer N. Avari Silva | Maria Berkman

Maria Berkman

Head of MedTech, Broadview Ventures | Managing Director, Longview Ventures

Broadview Ventures and Longview Ventures

Jennifer N. Avari Silva

Director Pediatric Electrophysiology

Washington University SOM


08:45 AM (EDT) - 09:30 AM (EDT)

Main Stage

John Halamka | Jagmeet Singh

John D. Halamka, MD, MS

President of the Mayo Clinic Platform

Mayo Clinic Platform

Jagmeet Singh

Professor of Medicine | Cardiac Electrophysiologist & Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program

Harvard Medical School | Massachusetts General Hospital Heart Center

September 05, 2024


01:15 PM (EDT) - 02:00 PM (EDT)

Main Stage

Chris Mansi | Suneet Mittal

Chris Mansi, MBBS, MBA

Co-founder & CEO

Suneet Mittal

Chair, Cardiovascular Service Line

Valley Health System